Search Within

Omar Ibrahim Abdel-Wahab

  1. "Early Drug Development Service"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (14)
Groups
  1. Center for Hematologic Malignancies (34)
  2. Department of Medicine (34)
  3. Early Drug Development Service (34)
  4. Executive Committee, Center for Hematologic Malignancies (34)
  5. GSK Faculty (34)
  6. Hematologic Malignancies, Division of (34)

More Groups

People
  1. David Hyman (34)
  2. Eli Diamond (34)
  3. Benjamin Durham (20)
  4. Raajit Rampal (20)
  5. Gary Ulaner (11)
  6. Mario Lacouture (11)

More People

Years
  1. 2020 (2)
  2. 2019 (5)
  3. 2018 (5)
  4. 2017 (4)
  5. 2016 (4)
  6. 2015 (7)

More Years

Publications
  1. Blood (12)
  2. Pediatric Blood and Cancer (6)
  3. Cancer Discovery (2)
  4. Neuro-Oncology (2)
  5. Blood Advances (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. Wiley Periodicals, Inc (6)
  3. Nature Publishing Group (3)
  4. American Association for Cancer Research (2)
  5. Oxford University Press (2)
  6. American Medical Association (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis analysis of data from the histology-independent, phase 2, open-label VE-BASKET study
    Journal Article

    Diamond, E. L.; Subbiah, V.; Lockhart, A. C.; Blay, J. Y.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J.; Erinjeri, J. P.; Torrisi, J.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Single-agent dabrafenib for BRAF(V600E)-mutated histiocytosis
    Journal Article

    Bhatia, A.; Ulaner, G.; Rampal, R.; Hyman, D. M.; Abdel-Wahab, O.; Durham, B. H.; Dogan, A.; Ozkaya, N.; Lacouture, M. E.; Hajdenberg, J.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Characterization of NTRK fusions and therapeutic response to NTRK inhibition in hematologic malignancies
    Meeting Abstract

    Taylor, J.; Marcelus, C.; Pavlick, D.; Benayed, R.; Yoshimi, A.; Cocco, E.; Durham, B. H.; Hechtman, J. F.; Chung, Y. R.; Mullaney, K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Phase 2 trial of single-agent cobimetinib for adults with BRAF V600-mutant and wild-type histiocytic disorders
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Dogan, A.; Hyman, D. M.; Rampal, R. K.; Ulaner, G.; Brody, L.; Abdel-Wahab, O.
    Blood (2017)

    Fulltext@MSK | Save
  • Single-agent dabrafenib for intracranial BRAF(V600E)-mutated histiocytosis
    Meeting Abstract

    Bhatia, A.; Ulaner, G.; Rampal, R.; Hyman, D.; Abdel-Wahab, O.; Durham, B.; Hajdenberg, J.; Ganzel, C.; Diamond, E.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Phase 2 trial of single-agent Cobimetinib for adults with histiocytic disorders: Interim results
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Dogan, A.; Hyman, D. M.; Rampal, R.; Ulaner, G.; Brody, L.; Abdel-Wahab, O.
    Pediatric Blood and Cancer (2017)

    Fulltext@MSK | Save
  • Frequent clinical overlap of histiocytic neoplasms and WHO-classified myeloid malignancies leads to functional insights into the cell-of-origin of histiocytoses
    Meeting Abstract

    Durham, B. H.; Yoshimi, A.; Papo, M.; Chung, Y. R.; Ozkaya, N.; Ganzel, C.; Dogan, A.; Hyman, D. M.; Park, C. Y.; Rampal, R. K.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Vemurafenib in patients with Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study
    Meeting Abstract

    Diamond, E. L.; Subbiah, V.; Lockhart, C.; Blay, J. Y.; Faris, J. E.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J. S.; Erinjeri, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies
    Journal Article

    Momtaz, P.; Pentsova, E.; Abdel-Wahab, O.; Diamond, E.; Hyman, D.; Merghoub, T.; You, D.; Gasmi, B.; Viale, A.; Chapman, P. B.
    Oncotarget (2016)

    Fulltext@MSK | Save
  • Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease
    Journal Article

    Diamond, E. L.; Hatzoglou, V.; Patel, S.; Abdel-Wahab, O.; Rampal, R.; Hyman, D. M.; Holodny, A. I.; Raj, A.
    Orphanet Journal of Rare Diseases (2016)

    Fulltext@MSK | Save